Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Number of holders
-
773
-
Total 13F shares, excl. options
-
487,041,912
-
Shares change
-
+11,861,493
-
Total reported value, excl. options
-
$25,535,694,806
-
Value change
-
+$617,581,810
-
Put/Call ratio
-
31.24%
-
Number of buys
-
322
-
Number of sells
-
-364
-
Price
-
$52.42
Significant Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q2 2014
899 filings reported holding TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share as of Q2 2014.
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) has 773 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 487,041,912 shares
of 1,147,663,152 outstanding shares and own 42.44% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (54,981,962 shares), FMR LLC (39,747,097 shares), Capital Research Global Investors (32,895,152 shares), Invesco Ltd. (19,626,769 shares), Mondrian Investment Partners LTD (17,315,878 shares), LAZARD ASSET MANAGEMENT LLC (15,283,002 shares), WELLINGTON MANAGEMENT CO LLP (14,029,142 shares), Allianz Asset Management AG (12,830,101 shares), PointState Capital LP (12,475,105 shares), and BARROW HANLEY MEWHINNEY & STRAUSS LLC (10,868,770 shares).
This table shows the top 773 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.